| John N Beattie, MD | |
|
1200 Sixth St, Suite 200, Traverse City, MI 49684-2369 | |
| (231) 935-5800 | |
| (231) 935-5799 |
| Full Name | John N Beattie |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 32 Years |
| Location | 1200 Sixth St, Traverse City, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265428718 | NPI | - | NPPES |
| 4204751 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 4301068118 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Munson Medical Center | Traverse city, MI | Hospital |
| Munson Healthcare Grayling Hospital | Grayling, MI | Hospital |
| Munson Healthcare Manistee Hospital | Manistee, MI | Hospital |
| Munson Healthcare Otsego Memorial Hospital | Gaylord, MI | Hospital |
| Kalkaska Memorial Health Center | Kalkaska, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Munson Medical Group | 8820277015 | 135 |
News Archive
MINNEAPOLIS - In just two years, people with type 2 diabetes experienced negative changes in their ability to regulate blood flow in the brain, which was associated with lower scores on tests of cognition skills and their ability to perform their daily activities, according to a new study published in the July 8, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.
Over 50 million people across the world suffer from epilepsy, making it the most common serious neurological disorder for which there is no cure. The causes for epilepsy are insufficiently understood with currently available treatments being sub-optimal and with a significant proportion of patients not responding
Quantros, a leading provider of clinically-focused data management and decision support solutions for the healthcare industry, will demonstrate several new patient safety improvement solutions at the 22nd Annual Institute for Healthcare Improvement National Forum on Quality Improvement in Health Care, Dec. 5 to 8 in Orlando, FL.
New treatments for intestinal failure and other intestinal absorption disorders are a step closer to the patients who need them after a discovery in Kelly Tappenden's University of Illinois laboratory.
In response to concerns from hospitals to prepare for eventual pandemic flu outbreaks, the French company AirInSpace, with support from ESA's Technology Transfer Programme, has successfully adapted technology developed to protect astronauts for use in critical care centres to protect immune-deficient patients against airborne pathogens such as the avian flu virus.
› Verified 5 days ago
| Entity Name | Munson Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083761860 PECOS PAC ID: 3072426287 Enrollment ID: O20040108000904 |
News Archive
MINNEAPOLIS - In just two years, people with type 2 diabetes experienced negative changes in their ability to regulate blood flow in the brain, which was associated with lower scores on tests of cognition skills and their ability to perform their daily activities, according to a new study published in the July 8, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.
Over 50 million people across the world suffer from epilepsy, making it the most common serious neurological disorder for which there is no cure. The causes for epilepsy are insufficiently understood with currently available treatments being sub-optimal and with a significant proportion of patients not responding
Quantros, a leading provider of clinically-focused data management and decision support solutions for the healthcare industry, will demonstrate several new patient safety improvement solutions at the 22nd Annual Institute for Healthcare Improvement National Forum on Quality Improvement in Health Care, Dec. 5 to 8 in Orlando, FL.
New treatments for intestinal failure and other intestinal absorption disorders are a step closer to the patients who need them after a discovery in Kelly Tappenden's University of Illinois laboratory.
In response to concerns from hospitals to prepare for eventual pandemic flu outbreaks, the French company AirInSpace, with support from ESA's Technology Transfer Programme, has successfully adapted technology developed to protect astronauts for use in critical care centres to protect immune-deficient patients against airborne pathogens such as the avian flu virus.
› Verified 5 days ago
| Entity Name | Munson Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821398322 PECOS PAC ID: 8820277015 Enrollment ID: O20110120000061 |
News Archive
MINNEAPOLIS - In just two years, people with type 2 diabetes experienced negative changes in their ability to regulate blood flow in the brain, which was associated with lower scores on tests of cognition skills and their ability to perform their daily activities, according to a new study published in the July 8, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.
Over 50 million people across the world suffer from epilepsy, making it the most common serious neurological disorder for which there is no cure. The causes for epilepsy are insufficiently understood with currently available treatments being sub-optimal and with a significant proportion of patients not responding
Quantros, a leading provider of clinically-focused data management and decision support solutions for the healthcare industry, will demonstrate several new patient safety improvement solutions at the 22nd Annual Institute for Healthcare Improvement National Forum on Quality Improvement in Health Care, Dec. 5 to 8 in Orlando, FL.
New treatments for intestinal failure and other intestinal absorption disorders are a step closer to the patients who need them after a discovery in Kelly Tappenden's University of Illinois laboratory.
In response to concerns from hospitals to prepare for eventual pandemic flu outbreaks, the French company AirInSpace, with support from ESA's Technology Transfer Programme, has successfully adapted technology developed to protect astronauts for use in critical care centres to protect immune-deficient patients against airborne pathogens such as the avian flu virus.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John N Beattie, MD 2891 Momentum Pl, Chicago, IL 60689-5328 Ph: (231) 935-5800 | John N Beattie, MD 1200 Sixth St, Suite 200, Traverse City, MI 49684-2369 Ph: (231) 935-5800 |
News Archive
MINNEAPOLIS - In just two years, people with type 2 diabetes experienced negative changes in their ability to regulate blood flow in the brain, which was associated with lower scores on tests of cognition skills and their ability to perform their daily activities, according to a new study published in the July 8, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.
Over 50 million people across the world suffer from epilepsy, making it the most common serious neurological disorder for which there is no cure. The causes for epilepsy are insufficiently understood with currently available treatments being sub-optimal and with a significant proportion of patients not responding
Quantros, a leading provider of clinically-focused data management and decision support solutions for the healthcare industry, will demonstrate several new patient safety improvement solutions at the 22nd Annual Institute for Healthcare Improvement National Forum on Quality Improvement in Health Care, Dec. 5 to 8 in Orlando, FL.
New treatments for intestinal failure and other intestinal absorption disorders are a step closer to the patients who need them after a discovery in Kelly Tappenden's University of Illinois laboratory.
In response to concerns from hospitals to prepare for eventual pandemic flu outbreaks, the French company AirInSpace, with support from ESA's Technology Transfer Programme, has successfully adapted technology developed to protect astronauts for use in critical care centres to protect immune-deficient patients against airborne pathogens such as the avian flu virus.
› Verified 5 days ago
John P Milliken, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 224 Circle Dr, Traverse City, MI 49684 Phone: 231-935-0525 Fax: 231-935-0529 | |
Dr. David R Hendricks, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 153 1/2 E Front St, Traverse City, MI 49684 Phone: 231-941-6670 Fax: 231-941-6675 | |
Dr. Jill Elizabeth Vollbrecht, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5015 N Royal Dr, Traverse City, MI 49684 Phone: 231-935-0850 Fax: 231-935-0850 | |
Dr. Katrina Marie Lawrence-wolff, DO Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 3537 W Front St Ste A, Traverse City, MI 49684 Phone: 231-935-8330 Fax: 231-935-3437 | |
Steven M. Lamie, M. D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3537 W Front St, Suite I, Traverse City, MI 49684 Phone: 231-935-8950 Fax: 231-935-8868 | |
Anne M Hepner, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1200 Sixth St, Suite 200, Traverse City, MI 49684 Phone: 231-935-5800 Fax: 231-935-5799 | |
Mark V Galan, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4100 Park Forest Dr, Suite 208, Traverse City, MI 49684 Phone: 231-935-5710 Fax: 231-935-9045 |